BioSpace News Archive

Business

TransEnterix Provides Corporate Update

Announces fourth Senhance System sale in second quarter of 2018

July 2, 2018
·
4 min read
FDA

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy as First-Line Treatment for Metastatic Squamous Non-Small Cell Lung Cancer

Application Based on Data from Pivotal Phase 3 KEYNOTE-407 Trial

July 2, 2018
·
27 min read
FDA

Compugen Announces FDA Clearance of IND Application for COM701, a First-in-class Immuno-Oncology Therapeutic Antibody

A Phase 1 trial in patients with advanced solid tumors is to be conducted at multiple centers in the United States

July 2, 2018
·
6 min read
Drug Development

CTI BioPharma Announces the Continuation without Modification of PAC203 Phase 2 Study of Pacritinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib

The IDMC did not identify any drug- or dose-related safety concerns and specifically did not identify any concerns about cardiac or bleeding events.

July 2, 2018
·
5 min read
FDA

FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia

Novel Regimen Enables Physicians to Fully Dose Up to Two Months of ARISTADA Treatment on Day One

July 2, 2018
·
14 min read
Drug Development

Verastem Oncology to Participate in the Oppenheimer Boston Oncology Insight Summit

Verastem, Inc. today announced that the Company will participate in the Oppenheimer Boston Oncology Insight Summit on July 10-11, 2018, in Boston, Massachusetts.

July 2, 2018
·
2 min read
Business

Onco360 Selected for BRAFTOVI ™ (encorafenib) and MEKTOVI® (binimetinib) Limited Distribution Pharmacy Network

BRAFTOVI and MEKTOVI provide another important therapeutic option for patients with unresectable or metastatic melanoma with BRAF B600E or BRAFV600K mutations

July 2, 2018
·
2 min read
Deals

AvaCare Medical Acquires Murse World

AvaCare Medical owners’ acquisition of Murse World brings new value to the healthcare industry

July 2, 2018
·
1 min read
Pharm Country

Novocure to Report Second Quarter 2018 Financial Results

Novocure announced today that it will report financial results for the second quarter 2018 on Thursday, July 26, 2018, before the U.S. financial markets open.

July 2, 2018
·
1 min read
Policy

EVIO Inc. Announces the Filing of Preliminary Non-Offering Prospectus

EVIO Inc. is pleased to announce it has filed and obtained a receipt for its preliminary non-offering prospectus with the Ontario Securities Commission

July 2, 2018
·
2 min read